This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
Journal of Inherited Metabolic Disease Open Access 31 May 2017
-
Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models
Journal of Translational Medicine Open Access 01 May 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. Early clinical data raise the bar for hemophilia gene therapies. Nat Biotechnol 34, 999–1001 (2016). https://doi.org/10.1038/nbt1016-999
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1016-999
This article is cited by
-
Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models
Journal of Translational Medicine (2017)
-
After Glybera's withdrawal, what's next for gene therapy?
Nature Biotechnology (2017)
-
Blood feud erupts over Roche's bispecific antibody for hemophilia
Nature Biotechnology (2017)
-
Delivering efficient liver-directed AAV-mediated gene therapy
Gene Therapy (2017)
-
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
Journal of Inherited Metabolic Disease (2017)